Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study

BACKGROUND: Regorafenib is a multi-kinase inhibitor approved for treatment of refractory advanced colorectal cancer. It was found in the clinical trials to have a modest benefit and significant toxicity. Our aim was to assess the outcome in our local clinic practice. PATIENTS AND METHODS: Records of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Med Insights Oncol
Prif Awduron: Aljubran, Ali, Elshenawy, Mahmoud A, Kandil, Magdy, Zahir, Muhammed N, Shaheen, Ahmed, Gad, Ahmed, Alshaer, Omar, Alzahrani, Ahmed, Eldali, Abdelmonem, Bazarbashi, Shouki
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2019
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354297/
https://ncbi.nlm.nih.gov/pubmed/30728734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179554918825447
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg